Association between obstructive sleep apnea and nonalcoholic fatty liver disease

S. Abd-Elrafea (Alexandria, Egypt), H. Shafiek (Alexandria, Egypt), P. Salem (Alexandria, Egypt), N. Abd-Elwahab (Alexandria, Egypt)

Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Session: Impact of sleep-disordered breathing in other diseases
Session type: Thematic Poster
Number: 849
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Abd-Elrafea (Alexandria, Egypt), H. Shafiek (Alexandria, Egypt), P. Salem (Alexandria, Egypt), N. Abd-Elwahab (Alexandria, Egypt). Association between obstructive sleep apnea and nonalcoholic fatty liver disease. 849

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease.
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019

The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease.
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012


Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010


Relationship between OSA and non-alcoholic fatty liver disease
Source: ERS Conference
Year: 2015

Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011

Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016
Year: 2017



Independent association between obstructive sleep apnea severity and liver stiffness
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018



Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea
Source: Eur Respir J 2011; 37: 1418-1423
Year: 2011



Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013



Chronic obstructive pulmonary disease in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009

Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Prevalence of thyroid disease in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011


Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Efficacy of AUTO-CPAP titration in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001

Visceral fat in non-to-moderate and severe obstructive sleep apnoea
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012


Prevalence of obstructive airway disease in patients with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012